Contact us (+ 7 (921) 446-25-10)
Texting is available for authorized users.
Please register or log in at the website.
Your request for online training has been sent. Cbonds managers will be in touch with you shortly. Thank you!

Insulet — bonds & company profile

company Insulet
full company name Insulet Corporation
country of risk USA
country of registration USA
industry Healthсare

Company details

  • pre-LEI / LEI
  • CIK


Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. Insulet Corporation was founded in 2000 and is based in Bedford, Massachusetts.

Outstanding bond issues amount

Сurrency Outstanding bond issues Cumulative volume
USD 2 1 202 500 000


Issue Volume, mln Status
Insulet, 0.375% 1sep2026, USD (Conv.) 800 USD outstanding
Insulet, 1.375% 15nov2024, USD (Conv.) 403 USD outstanding
Insulet, 1.375% 15nov2024, USD 403 USD early redeemed
Insulet, 2% 15jun2019, USD (Conv.) 201 USD redeemed

Consolidated IFRS reports

year 1 Q 2 Q 3 Q 4 Q
0.33 M eng
0.33 M eng
0.39 M eng
0.39 M eng
0.42 M eng
1.04 M eng
0.41 M eng
0.5 M eng
0.44 M eng
1.08 M eng

Cbonds is a global fixed income data platform
  • Cbonds is a global data platform on bond market
  • Coverage: more than 170 countries and 250,000 domestic and international bonds
  • Various ways to get data: descriptive data and bond prices - website, xls add-in, mobile app
  • Analytical functionality: bond market screener, Watchlist, market maps and other tools